Cargando…
EGFR may participate in immune evasion through regulation of B7-H5 expression in non-small cell lung carcinoma
Lung cancer is one of the most prevalent malignancies worldwide; it has been ranked the most lethal type of cancer. Non-small cell lung carcinoma (NSCLC) comprises >80% of all types of lung cancer. Although certain achievements have been made in the treatment of NSCLC, including the targeted gene...
Autores principales: | Dong, Zhaohui, Zhang, Lanying, Xu, Wei, Zhang, Gensheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131583/ https://www.ncbi.nlm.nih.gov/pubmed/30106102 http://dx.doi.org/10.3892/mmr.2018.9361 |
Ejemplares similares
-
Tumour Microenvironment and Immune Evasion in EGFR Addicted NSCLC: Hurdles and Possibilities
por: Santaniello, Antonio, et al.
Publicado: (2019) -
PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy
por: Xu, Yiqi, et al.
Publicado: (2021) -
Circulating PD‐1 (+) cells may participate in immune evasion in peripheral T‐cell lymphoma and chidamide enhance antitumor activity of PD‐1 (+) cells
por: Zhang, Wei, et al.
Publicado: (2019) -
Hijacking Factor H for Complement Immune Evasion
por: Moore, Sara R., et al.
Publicado: (2021) -
Molecular switches regulating the potency and immune evasiveness of SARS-CoV-2 spike protein
por: Wan, Yushun, et al.
Publicado: (2021)